TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of Participants With at Least a Moderate EULAR Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Troponin value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Brain Natriuretic Peptide (BNP/proBNP) value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Renal Clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change from Baseline Social Responsiveness Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: PSA Decline of at Least 50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: changes in procalcitonin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the sympathetic neural response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Auditory Hallucinations Rating Scale (AHRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Diagnosis of left ventricular dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cumulative Morbidity and Mortality Rate
Endpoint domain: Mortality/survival
Primary endpoint: Rate of Recurrent Ischemic Stroke in the Target Territory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: SUV measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in adherence rate
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Distance between measured Cricoid cartilage and Ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of difficulty to locate Cricoid cartilage NRS score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total time required for assessment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in contact phase activation induced by hemodialysis treatment (plasma kallikrein)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in contact phase activation induced by hemodialysis treatment (plasma fXIa)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in contact phase activation induced by hemodialysis treatment (plasma fXIIa)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Prevalence of dysplastic lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: maximum tolerated dose of TMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Subjects With a Vaccine Response for Anti-glycoprotein E (Anti-gE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adjusted Geometric Mean Concentrations (GMCs) for Anti-gE Antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: New development or progression of Acute Kidney Injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Gestational Weight Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: first-attempt intubation success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: intubation difficulty
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Fetal plasma copeptin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictive markers of preeclampsia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Status of Mild or Better on Physician Global Assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Tendon Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Integration of Induced Tissue With Underlying Tendon
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of Participants With a Re-Tear
Endpoint domain: Adverse events/effects
Primary endpoint: Fear and anxiety potentiated startle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation Coefficient Between DCE-MRI Perfusion Parameters and Response of Target Lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma total exposure (AUCτ,ss)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma maximum exposure (Cmax,ss)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma minimum exposure (Cmin,ss)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Anesthesia Stat critical events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in lipid profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of additional diagnoses made
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of diagnoses not made
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progressive cognitive impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Diagnostic accuracy of PET/MRI for malignancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Need for non-invasive ventilation
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Device or Procedure Related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Successful Navigation to Targeted Peripheral Pulmonary Lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Angiographic Outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Neurological Morbidity and Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Prevalence of myelofibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Neuropathy evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Acceptance for kidney transplantation
Endpoint domain: Mortality/survival
Primary endpoint: Depressive symptoms measured by GDS scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sit-to-stand test (STS60)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary protein remission rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Convenience and feasibility of carrying out a multi-night AMP study in the home
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Maximum tolerated dose of NK cells
Endpoint domain: Adverse events/effects
Endpoint subdomain: Any subdomain
Primary endpoint: Time to Headache Pain Freedom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Absence of Most Bothersome Symptom (MBS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gray Oral Reading Rest, Fourth Edition (GORT-4)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children's Depression Rating Scale Revised (CDRS-R)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in LARS score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of Deterioration in Neurocognitive Functioning (NF) at Month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Health Related Quality of Life (QoL) Scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Safety of A(H1N1)v influenza vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Measurement of von Willebrand factor multimers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Von Willebrand factor antigen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Frequency of evaluation of preclinical target organs damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in biomarker levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Local Relapse
Endpoint domain: Mortality/survival
Primary endpoint: Cognitive Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in global PSQI Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Participants With Laboratory Confirmed Influenza
Endpoint domain: Adverse events/effects
Primary endpoint: Change in daily servings of fruit/vegetables
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in energy density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in quality of life
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Gait Kinematics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peritoneal transport capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Mean Daily Walking Distance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Perceived Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability to clinicians
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Acceptability to patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: patient interest in N1 Headache App
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: user compliance for N1 Headache App
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Changes in midfoot frontal plane range of motion during stance phase of gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in ultrasound thickness measures of the abductor hallucis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Dropout rate in the Paleolithic lifestyle intervention group
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Longitudinal body composition changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Behavioral Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 7-day death
Endpoint domain: Mortality/survival
Primary endpoint: 7-day ICU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Renal replacement therapy at any time after dialysis
Endpoint domain: Mortality/survival
Primary endpoint: Change in Daily Life Physical Activity (DLPA) in Minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Total Sleep Time (TST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Sleep Efficiency (SE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Fugl-Meyer Upper Extremity Assessment Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: skin tissue glucose concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in Morning Pre-dose FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pharmacodynamics of Ticagrelor on P2Y12 receptor blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pharmacodynamics of Clopidogrel P2Y12 receptor blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Successful collection of samples
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: changes in LARS score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bioequivalence of D961H sachet and capsule
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects at risk for airway obstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: rate of patients presenting at least one toxicity grade≥3
Endpoint domain: Adverse events/effects
Primary endpoint: Pelvic realignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: uPi evolution during surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetic parameters of orvepitant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased Serum Retinol Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Decreased Prevalence of Vitamin A deficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline high frequency (HF) value at 1 week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival of Intensive care unit (ICU) stay
Endpoint domain: Mortality/survival
Primary endpoint: BODE Index change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total score in the Treatment Satisfaction Questionnaire for Medication (TSQM)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: change in bystander behavioral intention
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: change in attitudes towards sexual violence and harassment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Survival rate on Day 90
Endpoint domain: Mortality/survival
Primary endpoint: time necessary to intubate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serious respiratory failure (SRF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: VTE detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Box and Block Finger Prehension Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: supplemental oxygen-free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of the device during deployment and short-term implantation
Endpoint domain: Adverse events/effects
Primary endpoint: Factors disturbing vascular surgeons
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Dynamic postural balance tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Static postural balance tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypertonia Assessment Tool-Discriminate (HAT-D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Barry-Albright Dystonia scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-intravitreal injection inflammatory response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of patients achieving target LDL-C > 2.0 mmol/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of intrauterine adhesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Inpatient caloric intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of Subjects Achieving PASI-75
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean Percent Change in PASI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Left Ventricular Ejection Fraction reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Steroid Sensitivity in Vivo Symptom Scores - Trouble With Sense of Smell
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Steroid Sensitivity in Vivo Nasal Endoscopy Polyp Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trunk Impairment Scale modified Norwegian Version
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: amount of postoperation abdominal drainage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of participants suffering from insomnia
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in energy dense food consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in nutrient dense food consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Clinical improvement during hospitalization
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Ventricular strain reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Early mortality rate from pulmonary embolism
Endpoint domain: Mortality/survival
Primary endpoint: CPV-measured pre-/post-score difference
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: CPV-measured value of care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of subjects with severe or documented symptomatic hypoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean post test score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: prevalence of stress urinary incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of Patients With Investigator Defined Drug-related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Accuracy of anatomic landmarks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composition and diversity of gut microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Occurrence of bacterial infection
Endpoint domain: Adverse events/effects
Primary endpoint: Variation of the Concentration of Phleum Pratense Extract
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum bactericidal antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change activity behavior (minutes per week in Total physical activity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change sedentary behavior (minutes per week of sedentary behavior)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change dietary intake (Fruit and vegetable servings, % fat, sodium and fiber intake)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: clinical activity of the treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Event Free at 4 months
Endpoint domain: Mortality/survival
Primary endpoint: paired pre-/post-treatment tumor Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: number of intubations
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity of Flurpiridaz F 18 PET MPI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Specificity of Flurpiridaz PET MPI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Major fatal and non fatal ischemic cardiovascular events
Endpoint domain: Mortality/survival
Primary endpoint: Cancer any kind except for basal cell skin carcinoma
Endpoint domain: Mortality/survival
Primary endpoint: Normal vestibular response to provocative tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative local tumor progression (LTP) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Composite of major cardiovascular disease events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pain/Disability Using the Zurich Claudication Questionnaire (ZCQ) Physical Function Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pain/Disability Using the Zurich Claudication Questionnaire (ZCQ) Symptom Severity Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants Who Maintained or Improved in Neurological Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Impulse Oscillation System
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Sputum Wet Weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Short-term and long-term toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: intracranial progression-free survival (iPFS)
Endpoint domain: Mortality/survival